Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Jun 01, 2016 $30.11 $30.11 $30.11 $30.11 776 380
May 31, 2016 $30.07 $30.07 $30.07 $30.07 1 123 834
May 27, 2016 $29.04 $29.04 $29.04 $29.04 607 945
May 26, 2016 $29.26 $29.26 $29.26 $29.26 1 017 159
May 25, 2016 $27.74 $27.74 $27.74 $27.74 450 515
May 24, 2016 $28.36 $28.36 $28.36 $28.36 429 838
May 23, 2016 $27.57 $27.57 $27.57 $27.57 476 088
May 20, 2016 $27.96 $27.96 $27.96 $27.96 729 594
May 19, 2016 $26.61 $26.61 $26.61 $26.61 618 111
May 18, 2016 $26.79 $26.79 $26.79 $26.79 753 786
May 17, 2016 $25.26 $25.26 $25.26 $25.26 501 754
May 16, 2016 $25.48 $25.48 $25.48 $25.48 812 474
May 13, 2016 $24.01 $24.01 $24.01 $24.01 408 180
May 12, 2016 $23.99 $23.99 $23.99 $23.99 641 822
May 11, 2016 $25.62 $25.62 $25.62 $25.62 371 557
May 10, 2016 $26.12 $26.12 $26.12 $26.12 443 230
May 09, 2016 $26.22 $26.22 $26.22 $26.22 551 784
May 06, 2016 $25.10 $25.10 $25.10 $25.10 443 488
May 05, 2016 $25.21 $25.21 $25.21 $25.21 419 166
May 04, 2016 $25.84 $25.84 $25.84 $25.84 653 550
May 03, 2016 $26.54 $26.54 $26.54 $26.54 522 925
May 02, 2016 $27.48 $27.48 $27.48 $27.48 905 645
Apr 29, 2016 $26.55 $26.55 $26.55 $26.55 1 007 723
Apr 28, 2016 $27.58 $27.58 $27.58 $27.58 702 873
Apr 27, 2016 $28.13 $28.13 $28.13 $28.13 806 797
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT